Provided are methods relating to compositions that include a CDP- topoisomerase inhibitor, e.g., a CDP-camptothecin or camptothecin derivative conjugate, e.g., CRLX101.
申请公布号
AU2010295646(A1)
申请公布日期
2012.04.05
申请号
AU20100295646
申请日期
2010.09.15
申请人
CERULEAN PHARMA INC.;CITY OF HOPE;RYAN, JOHN;YEN, YUN;SCHLUEP, THOMAS;CALANDO PHARMACEUTICALS, INC.
